Back to IMRX
Connor, Clark & Lunn Investment Management Ltd. → IMRX
Connor, Clark & Lunn Investment Management Ltd. IMRX Position History
Immuneering Corporation • Healthcare
Quarters held
4
Latest value
$2.4M
Q3 2026
Peak value
$3M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $873K |
| Q1 2026 | $2.1M |
| Q2 2026 | $3M |
| Q3 2026 | $2.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $2.4M | 580.2K | — | — |
| Q2 2026 | $3M | 601.3K | — | — |
| Q1 2026 | $2.1M | 400.4K | — | — |
| Q4 2025 | $873K | 132.7K | — | — |